Search results
Annie F. Luetkemeyer (born April 13, 1972, Baltimore, Maryland, U.S.) is an American physician and researcher who is Professor of Medicine and Infectious Diseases at the University of California, San Francisco.
Annie Luetkemeyer is a clinical professor of HIV, infectious disease, and global medicine at UCSF. She has expertise in HIV therapeutic strategies, COVID-19 treatment and prevention, and viral hepatitis.
Annie Luetkemeyer, MD. Education and Training. Interests. Websites. In The News. Clinical Trials. Academic Senate. Twitter. Publications. Education and Training. Interests. HIV therapeutic strategies, COVID-19 treatment and prevention, Sexually Transmitted Infections, DoxyPEP, Viral hepatitis, Hepatitis C, Hepatitis Elimination. Websites.
annie.luetkemeyer@ucsf.edu. +1 415 502-5753. I specialize in HIV/AIDS and have clinical responsibilities including outpatient services at the San Francisco General Hospital HIV clinic as well as inpatient services on the HIV/AIDS, general medicine, and infectious diseases consult services. I direct the HIV Clinical Trials Group at SFGH, which ...
Annie Luetkemeyer, MD, is a UCSF infectious disease physician and researcher who leads clinical trials of promising therapies for COVID-19, including remdesivir and convalescent plasma. She also cares for HIV and hepatitis C patients and advocates for vulnerable populations affected by the pandemic.
Comparison of Quantiferon to Conventional Tuberculin Skin Testing for the Diagnosis of Latent Tuberculosis Infection (LTBI) in HIV Positive Subjects. Mentored Scientist Award, Spring 2005.
Annie Luetkemeyer's 25 research works with 6,553 citations and 2,947 reads, including: Rapid Development of an Integrated Network Infrastructure to Conduct Phase 3 COVID-19 Vaccine Trials
